The calculation of diluted earnings per share includes the dilutive effect of equity based awards that were outstanding during the three and six months ended March 29, 2019, and March 30, 2018, using the treasury stock method.
This information should be read in conjunction with the Company’s financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended September 28, 2018, filed with the SEC on November 15, 2018, as amended by Amendment No.
Item 1A.
To date, there have been no material impairment losses on accounts receivable.
This ASU requires that the income statement reflect the measurement of credit losses for newly recognized financial assets as well as the expected increases or decreases of expected credit losses that have taken place during the period.
In certain instances, the Company’s indemnities do not provide for any limitation of the maximum potential future payments the Company could be obligated to make.
Certain information and footnote disclosures, normally included in annual consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), have been condensed or omitted pursuant to those rules and regulations.
amortized cost.
In January 2016, the FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities (Topic 320), (“ASU 2016-01”).
The contractual maturities of noncurrent available-for-sale marketable securities were due within two years or less.
In reaching this conclusion, management considers the definition of the chief operating decision maker (“CODM”), how the business is defined by the CODM, the nature of the information provided to the CODM and how that information is used to make operating decisions, allocate resources and assess performance.Cash used in investing activities consists primarily of capital expenditures and cash paid related to the purchase of marketable securities, offset by cash received related to the sale or maturity of marketable securities.
Research and development expense increased as a percentage of net revenue, when compared with the corresponding periods in fiscal 2018, as a result of our increased investment in developing new technologies and products, as well as the decline in revenue.
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Our contractual obligations disclosure in the 2018 10-K has not materially changed since we filed that report.Conversely, decreases in the value of the United States dollar relative to other currencies could result in our suppliers raising their prices to continue doing business with us.From time to time the Company may also be involved in legal proceedings in the ordinary course of business.